The EIT Health Regulatory Pathways to Market Bootcamp is a 10-week programme that aims to help early-stage healthcare companies enter the European market.
Instituto Pedro Nunes (IPN) is participating in this EIT Health bootcamp, which is designed to help health innovation companies understand and navigate the regulated European health services market.
In order to ensure quality and cost-efficient healthcare in the European Union, patients, health professionals, payers and regulators need to know if new innovative technologies meet their needs.
This bootcamp is designed with a view to supporting healthcare innovation companies to understand and navigate the European healthcare market. The goal of this highly specialized program, adapted to the needs of these companies, is to give tools to early-stage startups, with a focus on medical devices and digital health, so that they can more easily access this market.
It is intended that companies acquire tools to develop a complete go-to-market strategy, such as regulatory strategy, health technology assessment, market entry, reimbursement options and access to funds, and strategic planning in order to access the market with all the requirements already in place.
IPN, through the Laboratory for Automation and Systems (LAS), will share its expertise in healthcare technology, medical devices and regulation, and provide guidance and mentorship to participating startups. The LAS has extensive experience in healthcare technologies, medical and in vitro devices and regulation. Learn more at https://www.ipn.pt/laboratorio/LAS/servico?id=2
Applications for the EIT Health Regulatory Pathways to Market Bootcamp can be made until March 20 here
On March 1 and 2, the Regulatory Pathways to Market Bootcamp started, during a meeting, which took place at IPN, in Coimbra, and counted with the participation of several partners, namely, Instituto Pedro Nunes (through the Laboratory for Automatics and Systems), Medical Valley EMN, Syreon Research Institute, Medtronic Iberica, Medtronic Portugal and COMPLEAR. During this meeting, the partners had the opportunity to discuss the project's next steps.